Lumexa Imaging Holdings

LMRI · NASDAQ

$10.68−$0.04 (−0.37%)TodayMarket closed ·
Prev close $10.72

About LMRI

Lumexa Imaging Holdings, Inc. engages in providing diagnostic imaging services. The company is headquartered in Raleigh, North Carolina and currently employs 4,064 full-time employees. The company went IPO on 2025-12-11. The firm offers a range of advanced imaging services (MRI, CT and PET scans) and routine diagnostic and screening imaging services (X-ray, ultrasound and mammography). The Company’s segments include Outpatient Imaging Centers (Outpatient) and Professional Services (Professional). The Outpatient segment consists of imaging centers that are owned or operated by it (either wholly owned or via unconsolidated affiliate), where it performs the imaging scan and provides the radiologist’s interpretation service. The Professional segment consists of professional interpretation services, where the imaging scan itself is performed at the hospital or point of care and not by it or its unconsolidated affiliates. The firm and its affiliates operate outpatient imaging center footprint in the United States, spanning 184 centers across 13 states and includes eight joint venture partnerships with health systems.

Employees
4,064
Headquarters
Raleigh, North Carolina
Listed
Dec 11, 2025
Sector
Health Care
Industry
Health Care Providers & Services

LMRI key statistics

Market cap
1.03B
Price-earnings ratio
0.00
Dividend yield
—
Average volume
421.64K
Volume
189.49K
Open price
$10.81
High today
$10.94
Low today
$10.65
52 Week high
$19.45
52 Week low
$6.45

Lumexa Imaging Holdings (LMRI) at a glance

As of Oct 20, 2026, Lumexa Imaging Holdings (LMRI) shares are priced at $10.68, giving the company a market cap of 1.03B and a price-to-earnings ratio of 0.00.

Today the stock has traded between $10.65 and $10.94. The current price is 0.3% above the day's low and 2.4% below its high.

Volume so far is 189.49K shares, below the average of 421.64K shares a day.

Over the past year Lumexa Imaging Holdings has ranged from $6.45 to $19.45, and now sits 33% of the way up that range.

Lumexa Imaging Holdings met or beat analyst EPS estimates in 2 of the last 3 quarters. In Q2 FY26 it reported $0.20 per share against an estimate of $0.1612.

The average analyst price target is $17.92, 67.8% above the current price, from 10 recent ratings.

Analyst ratings

Latest rating from each analyst over the past 12 months

100%of 10 analyst ratings say Buy
  • Buy100.0%
  • Hold0.0%
  • Sell0.0%
Price target · 10 analystsAvg $17.92
Low
$13.13
Now
$10.68
High
$24.15

LMRI earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 2 of the last 3 quarters, by 34.7% on average.

  1. Q4 FY25: reported -$0.20 per share against an estimate of $0.0729
  2. Q1 FY26: reported $0.18 per share against an estimate of $0.1239
  3. Q2 FY26: reported $0.20 per share against an estimate of $0.1612

LMRI news

  • Press releaseGlobe Newswire

    Lumexa Imaging Announces Joint Venture with Hospital for Special Surgery (HSS) to Expand Advanced Outpatient Imaging in New York

  • 12 Health Care Stocks Moving In Wednesday's Intraday Session

  • Lumexa Imaging Holdings Q1 2026 Earnings Call Transcript

  • 12 Health Care Stocks Moving In Monday's Pre-Market Session

  • Press releaseBusiness Wire

    Middleby Appoints Glenn Eisenberg To Board of Directors

  • 12 Health Care Stocks Moving In Wednesday's Pre-Market Session

  • Press releasePRNewswire

    Lumexa Imaging Announces Participation in Upcoming Investor Conferences

  • Press releasePRNewswire

    Lumexa Imaging's Dr. Jennifer L. Kemp Elected to RSNA Board, Advancing National Leadership in Quality and Patient-Centered Care

Similar companies

Companies in the same industry as Lumexa Imaging Holdings

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.